Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06618274
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-25
Brief Title:
Effectiveness of Central Oncology Navigation and the Use of an ORN
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Evaluating the Effectiveness of Central Oncology Navigation and the Use of an Oncology Research Navigator
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This health services interventional study investigates the effectiveness of central oncology navigation SOC alone and central oncology navigation with a new role called an oncology research navigator ORN who is embedded in central oncology navigation cancer care delivery This study will examine two patient cohorts Cohort 1 will enroll patients with new cancer appointments within genitourinary GU or thoracic cancers These clinics have not yet implemented the central navigation program Participants will be enrolled pre- and post-implementation of the central oncology navigator within these cancer groups to evaluate the effectiveness of the central oncology navigator alone The second cohort will enroll participants with new cancer appointments within gastrointestinal GI hematology and breast cancer clinics where the central navigation program was implemented These individuals will be randomized to receive standard of care which for these cancer types includes central oncology navigation or the intervention of an oncology research navigator in addition to SOC This intervention will involve baseline and biweekly follow-up for a total of 3 months Interactions with the ORN will include facilitating participation in supportive care services and clinical trials All participants will undergo baseline and follow-up patient-reported outcomes and data collection The study will evaluate the impact of the central oncology navigation program alone as well as the addition of the ORN on patient quality of life as well as enrollment into studies and participation in supportive care services Additional analyses will evaluate the impact of the central oncology navigation program on patient experience patient activation net promoter scores and overall survival
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None